drugset / Trial / NCT00941486
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this study is to evaluate the efficacy of FST-100 (PVP-I 0.4% and dexamethasone 0.1%) Ophthalmic Suspension in the treatment of suspected acute adenoviral conjunctivitis.
Timeline
- Start
- 2009-06-30
- Primary completion
- 2010-06-30
- Completion
- 2010-06-30
Outcome
Missed primary endpoint
release “there were too few subjects testing positive for a viral presence for the study to deliver meaningful results, and it was not statistically significant.” takeda.com ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | 0.1 % | Other |
| Subject | PVP-I | Unknown | 0.4 % | Other |